Last updated 22 days ago
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
850 patients around the world
Available in Puerto Rico, Spain, Colombia, Chile, Brazil, Argentina, Mexico, United States
Celgene
4Research sites
850Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Large B-cell lymphoma
Requirements for the patient
To 80 Years
All Gender
Medical requirements
Sites
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
Recruiting
Hospital Alemán
Recruiting
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires
Recruiting
Hospital Privado de Córdoba
Recruiting
StudyGOLSEEK-1
SponsorCelgene
Conditions
Large B-cell lymphoma
Requirements
To 80 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06356129
